These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 9145219)
21. Pharmacokinetics of flunixin in the cat: enterohepatic circulation and active transport mechanism in the liver. Horii Y; Ikenaga M; Shimoda M; Kokue E J Vet Pharmacol Ther; 2004 Apr; 27(2):65-9. PubMed ID: 15096102 [TBL] [Abstract][Full Text] [Related]
22. Development of an Enantioselective and Biomarker-Informed Translational Population Pharmacokinetic/Pharmacodynamic Model for Etodolac. de Miranda Silva C; Rocha A; Tozatto E; da Silva LM; Donadi EA; Dalla Costa T; Lanchote VL; Schmidt S; Bulitta JB AAPS J; 2017 Nov; 19(6):1814-1825. PubMed ID: 28875479 [TBL] [Abstract][Full Text] [Related]
23. A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats. Fukuyama T; Yamaoka K; Ohata Y; Nakagawa T Drug Metab Dispos; 1994; 22(3):479-85. PubMed ID: 8070327 [TBL] [Abstract][Full Text] [Related]
24. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. Marier JF; Vachon P; Gritsas A; Zhang J; Moreau JP; Ducharme MP J Pharmacol Exp Ther; 2002 Jul; 302(1):369-73. PubMed ID: 12065739 [TBL] [Abstract][Full Text] [Related]
25. Biliary excretion, metabolism and enterohepatic circulation of buprenorphine. Brewster D; Humphrey MJ; McLeavy MA Xenobiotica; 1981 Mar; 11(3):189-96. PubMed ID: 7293215 [TBL] [Abstract][Full Text] [Related]
26. Analysis of the Change in the Blood Concentration-Time Profile Caused by Complex Drug-Drug Interactions in the Liver Considering the Enterohepatic Circulation: Examining Whether the Inhibition Constants for Uptake, Metabolism, and Biliary Excretion Can be Recovered by the Analyses Using Physiologically Based Pharmacokinetic Modeling. Toshimoto K; Tomoda Y; Chiba K; Sugiyama Y J Pharm Sci; 2017 Sep; 106(9):2727-2738. PubMed ID: 28479365 [TBL] [Abstract][Full Text] [Related]
27. Isolation of an unknown metabolite of the non-steroidal anti-inflammatory drug etodolac and its identification as 5-hydroxy etodolac. Strickmann DB; Blaschke G J Pharm Biomed Anal; 2001 Jul; 25(5-6):977-84. PubMed ID: 11377082 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of methylergometrine in the rat: evidence for enterohepatic recirculation by a linked-rat model. Bredberg U; Paalzow L Pharm Res; 1990 Jan; 7(1):14-20. PubMed ID: 2300530 [TBL] [Abstract][Full Text] [Related]
29. Biliary excretion and enterohepatic cycling of glycyrrhizin in rats. Ichikawa T; Ishida S; Sakiya Y; Sawada Y; Hanano M J Pharm Sci; 1986 Jul; 75(7):672-5. PubMed ID: 3761168 [TBL] [Abstract][Full Text] [Related]
30. Enantioselective pharmacokinetics of etodolac in the rat: tissue distribution, tissue binding, and in vitro metabolism. Brocks DR; Jamali F J Pharm Sci; 1991 Nov; 80(11):1058-61. PubMed ID: 1839997 [TBL] [Abstract][Full Text] [Related]
31. Enterohepatic circulation of triiodothyronine (T3) in rats: importance of the microflora for the liberation and reabsorption of T3 from biliary T3 conjugates. Rutgers M; Heusdens FA; Bonthuis F; de Herder WW; Hazenberg MP; Visser TJ Endocrinology; 1989 Dec; 125(6):2822-30. PubMed ID: 2583041 [TBL] [Abstract][Full Text] [Related]
32. Biliary excretion and enterohepatic circulation of 1-nitropyrene metabolites in Fischer-344 rats. Medinsky MA; Shelton H; Bond JA; McClellan RO Biochem Pharmacol; 1985 Jul; 34(13):2325-30. PubMed ID: 4015679 [TBL] [Abstract][Full Text] [Related]
33. Enterohepatic circulation of methotrexate in rats in vivo. Steinberg SE; Campbell CL; Bleyer WA; Hillman RS Cancer Res; 1982 Apr; 42(4):1279-82. PubMed ID: 7060005 [TBL] [Abstract][Full Text] [Related]
34. Enterohepatic circulation of l-alpha-acetylmethadol in the rat. Roerig DL; Hasegawa AT; Wang RI J Pharmacol Exp Ther; 1980 May; 213(2):284-8. PubMed ID: 7365687 [TBL] [Abstract][Full Text] [Related]
35. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and enterohepatic circulation of 2-n-propyl-4-pentenoic acid in the rat. Singh K; Orr JM; Abbott FS Drug Metab Dispos; 1988; 16(6):848-52. PubMed ID: 2907464 [TBL] [Abstract][Full Text] [Related]
37. Investigation of the enterohepatic recirculation of Adriamycin and its metabolites by a linked-rat model. Behnia K; Boroujerdi M Cancer Chemother Pharmacol; 1998; 41(5):370-6. PubMed ID: 9523732 [TBL] [Abstract][Full Text] [Related]
38. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation. Maniez-Devos DM; Baurain R; Lesne M; Trouet A J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]